信息搜索
信息关键字：药
  

共有5246条记录

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239] [240] [241] [242] [243] [244] [245] [246] [247] [248] [249] [250] [251] [252] [253] [254] [255] [256] [257] [258] [259] [260] [261] [262] [263]

·申高制药2022年上半年亏损254.41万同比亏损增加产品销量及单价下降2022-8-19 21:45:10
·股票行情快报：百洋医药8月19日主力资金净卖出556.96万元2022-8-19 21:45:07
·片仔癀上半年净利逾13亿元医药制造营收贡献比例超47%2022-8-19 21:19:30
·百丰医药2022年上半年净利337.57万同比增长187.66%销售收入增长2022-8-19 21:03:29
·股票行情快报：沃华医药8月19日主力资金净卖出388.91万元2022-8-19 21:03:23
·股票行情快报：复星医药8月19日主力资金净卖出6678.14万元2022-8-19 20:38:09
·两天内市值蒸发125亿！“东北药茅”再遭“集采”重锤，16万股民心碎，平均每人亏近7.2万元2022-8-19 20:19:41
·瑞普生物：取得鸭坦布苏病毒病活疫苗（FX2010-180P株）兽药产品批准文号2022-8-19 19:30:25
·月内三收关注函！34%股权交易背后是未名医药子公司资产遭侵占？2022-8-19 19:25:42
·全宇制药2022年上半年亏损739.89万同比由盈转亏本期营业收入较上年同期有所下降2022-8-19 18:40:05
·恒瑞医药：上半年净利润21.19亿元同比下降20.55%2022-8-19 17:29:03
·翰宇药业：全资子公司醋酸去氨加压素原料药获得上市申请批准通知书2022-8-19 17:08:48
·上市公司舆情周报|海底捞预亏超2亿步长制药高价收购负资产2022-8-19 16:36:21
·生物医药板块跌1.06%沃森生物涨6.04%居首2022-8-19 16:31:42
·泽璟制药上半年亏损上市后连亏两年半IPO募资20亿元2022-8-19 16:29:24
·国家药监局：10月起化妆品电子注册证将正式实施2022-8-19 16:10:02
·华海药业：制剂产品左旋米那普仑缓释胶囊获得美国FDA暂时批准文号2022-8-19 15:50:10
·泽璟制药2022年上半年亏损2.47亿同比亏损增加研发支出较大2022-8-19 14:07:27
·光伏绝非万能灵药，一窝蜂跨界不可取2022-8-19 13:55:57
·一度跌停！医药大白马两天急跌18%，午间紧急发布利好！“鳗鱼王”涨停，业绩增长农牧概念股出炉2022-8-19 13:47:09

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239] [240] [241] [242] [243] [244] [245] [246] [247] [248] [249] [250] [251] [252] [253] [254] [255] [256] [257] [258] [259] [260] [261] [262] [263]